Categories
Archives
Receive Email Updates
-
-
Certified Licensing Professionals, Inc., 2021 Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner Pages
Archives
Monthly Archives: June 2014
URGENT – COMMENTS DEADLINE EXTENDED
The deadline for Myriad-Mayo comments has been extended by a month. Info on the USPTO website and can be found here.
Posted in USPTO Practice and Policy
Tagged biotechnology, biotechnology law, intellectual property, ip, Myriad, Patent Law, patents, USPTO, Warren Woessner
Leave a comment
USPTO issues post- Alice examination guidelines
A copy of the guidelines can be found here: alice_pec_25jun2014 I will comment on this later.
“We Don’t Need No Stinkin’ Patents” – Antibiotic and Antifungal Drugs Gain Non-Patent Exclusivity
Posted on the FDA Law Blog by Kurt Karst on June 19, 2014. After years of relative quiet, the Orange Book list of exclusivity terms has gotten quite a workout over the past year with the addition of several new terms … Continue reading
Posted in Hatch-Waxman
Tagged biotechnology law, Dalvance, FDA Law Blog, Hatch-Waxman, Kurt Karst, orange book, Warren Woessner
Leave a comment
CLS v Alice – Abstract Idea, Wherefore Art Thou?
Guest post from Brad Forrest, Shareholder at Schwegman Lundberg & Woessner, P.A. Passing on the opportunity to provide a usable test to determine what is an “abstract idea,” the Supreme court simply compared the idea underlying the claims in Alice … Continue reading